ArticleEuropean heart journal2026

Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.

Joakim Nordanstig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.